Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenjie Jessie Lu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Clinical Psychopharmacology|June 23, 2012
Reduced methadone clearance during aromatase inhibitionWenjie Jessie Lu, Nancy Thong, David A Flockhart
Breast Cancer Research and Treatment|March 11, 2011
Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancerWenjie Jessie Lu, Zeruesenay Desta, David A Flockhart
Chirality|September 29, 2011
Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoformsWenjie Jessie Lu, Valentina Ferlito, Cong Xu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2010
Methadone: a substrate and mechanism-based inhibitor of CYP19 (aromatase)Wenjie Jessie Lu, Robert Bies, Landry K Kamden, et al.
Breast Cancer Research and Treatment|August 5, 2011
The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agentsWenjie Jessie Lu, Cong Xu, Zifan Pei, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 5, 2013
Inhibition of cytochrome p450 enzymes by the e- and z-isomers of norendoxifenJinzhong Liu, Peter J Flockhart, Deshun Lu, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Clinical Psychopharmacology|June 23, 2012
Reduced methadone clearance during aromatase inhibitionWenjie Jessie Lu, Nancy Thong, David A Flockhart
Breast Cancer Research and Treatment|March 11, 2011
Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancerWenjie Jessie Lu, Zeruesenay Desta, David A Flockhart
Chirality|September 29, 2011
Enantiomers of naringenin as pleiotropic, stereoselective inhibitors of cytochrome P450 isoformsWenjie Jessie Lu, Valentina Ferlito, Cong Xu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 23, 2010
Methadone: a substrate and mechanism-based inhibitor of CYP19 (aromatase)Wenjie Jessie Lu, Robert Bies, Landry K Kamden, et al.
Breast Cancer Research and Treatment|August 5, 2011
The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agentsWenjie Jessie Lu, Cong Xu, Zifan Pei, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 5, 2013
Inhibition of cytochrome p450 enzymes by the e- and z-isomers of norendoxifenJinzhong Liu, Peter J Flockhart, Deshun Lu, et al.
Pageof 1